Related Experiment Video
Updated: Feb 4, 2026

Isolation of Stem Cells from Human Pancreatic Cancer Xenografts
Published on: September 26, 2010
Human PAF complexes in endocrine tumors and pancreatic cancer
Shonali Deb1, Moorthy P Ponnusamy2, Shantibhusan Senapati3
1a Department of Biochemistry and Molecular Biology, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-5870, USA. sbatra@unmc.edu.
Abstract:
The human RNA polymerase II-associated factor (hPAF) complex is comprised of five subunits that include hPaf1, parafibromin, hLeo1, hCtr9 and hSki8. This multifaceted complex was first identified in yeast (yPAF) and subsequently in Drosophila and humans. Recent advances in the study on hPAF have revealed various functions of the complex in humans that are similar to yPAF, including efficient transcription elongation, mRNA quality control and cell cycle regulation. A major component of the hPAF complex, hPaf1, is amplified and overexpressed in pancreatic cancer. The parafibromin subunit of the hPAF complex is a product of the hereditary hyperparathyroidism type 2 (HRPT-2) tumor-suppressor gene, which is mutated in the germ line of hyperparathyroidism-jaw tumor patients. This review evaluates the role of the hPAF complex and its individual subunits in endocrine and pancreatic cancers. It focuses on the functions of the hPAF complex and its individual subunits and dysregulation of the complex, thus providing an insight into its potential involvement in the development of endocrine cancers and other tumor types.
Insights
The human RNA polymerase II-associated factor (hPAF) complex plays roles in transcription and cell cycle regulation. Its subunits are implicated in pancreatic and endocrine cancers, suggesting a role in tumor development.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- The human RNA polymerase II-associated factor (hPAF) complex, comprising hPaf1, parafibromin, hLeo1, hCtr9, and hSki8, is conserved across species.
- hPAF functions in transcription elongation, mRNA quality control, and cell cycle regulation, similar to its yeast counterpart (yPAF).
Purpose of the Study:
- To review the role of the hPAF complex and its subunits in endocrine and pancreatic cancers.
- To explore the functions and dysregulation of hPAF in cancer development.
Main Methods:
- Literature review focusing on the hPAF complex and its subunits.
- Analysis of existing research on hPAF's involvement in cancer biology.
Main Results:
- hPaf1 subunit amplification and overexpression are observed in pancreatic cancer.
- The parafibromin subunit is linked to hereditary hyperparathyroidism type 2 (HRPT-2) and tumor suppression.
- Dysregulation of hPAF subunits is potentially involved in endocrine and other cancers.
Conclusions:
- The hPAF complex and its subunits are critical in regulating cellular processes relevant to cancer.
- Further investigation into hPAF's role could reveal new therapeutic targets for endocrine and pancreatic cancers.
More Related Videos
07:31Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
Related Concept Videos
Endocrine Signaling
What is the Endocrine System?
The Endocrine System
An Overview of the Endocrine System
The endocrine system collaborates...
Structures of the Endocrine System
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...